Multidrug- and Rifampicin-resistant Tuberculosis
1 clinical trials · Condition
◉ Watch Multidrug- and Rifampicin-resistant Tuberculosis
| Record | Firm | Date |
|---|---|---|
| BPaL(M) Regimen for the Treatment of MDR/RR-TB (NCT05381194) | Asan Medical Center | 2022-12-13 |
Track Multidrug- and Rifampicin-resistant Tuberculosis automatically
Every clearance here is in the API, with alerts when new ones post.